Management of Venous Thromboembolism
- 12 December 1996
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 335 (24) , 1816-1829
- https://doi.org/10.1056/nejm199612123352407
Abstract
Venous thromboembolism, which includes deep-vein thrombosis (usually involving leg veins) and pulmonary embolism, is a common cause of death. Treatment of affected patients reduces the incidence of fatal pulmonary embolism, but therapy should be based on the severity of disease and the potential for side effects. Decisions about the duration of therapy should be made by balancing the risks of continuing therapy against the risk of recurrence. In this review, the care of patients with venous thromboembolism will be discussed, with emphasis on recent advances.DiagnosisApproximately 75 percent of patients who present with suspected venous thrombosis or pulmonary embolism . . .Keywords
This publication has 78 references indexed in Scilit:
- Inferior vena cava filters. Indications, safety, effectivenessArchives of internal medicine (1960), 1992
- Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous ThrombosisNew England Journal of Medicine, 1990
- Intermittent compression units for the postphlebitic syndrome. A pilot studyArchives of internal medicine (1960), 1989
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- Serial Impedance Plethysmography for Suspected Deep Venous Thrombosis in OutpatientsNew England Journal of Medicine, 1986
- Long‐term Sequelae of Calf Vein Thrombosis Treated with Heparin or Low‐dose StreptokinaseActa Medica Scandinavica, 1986
- WarfarinNew England Journal of Medicine, 1984
- The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge.Circulation, 1983
- Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1982
- Survival Time of Prothrombin and Factors VII, IX and X after Completely Synthesis Blocking Doses of Coumarin DerivativesBritish Journal of Haematology, 1963